Performance of SynerGraft Decellularized Pulmonary Allografts Compared With Standard Cryopreserved Allografts: Results From Multiinstitutional Data Steve Bibevski, MD, PhD, Mark Ruzmetov, MD, PhD, Randall S. Fortuna, MD, Mark W. Turrentine, MD, John W. Brown, MD, Richard G. Ohye, MD The Annals of Thoracic Surgery Volume 103, Issue 3, Pages 869-874 (March 2017) DOI: 10.1016/j.athoracsur.2016.07.068 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Distribution of implanted SynerGrafts (CryoLife, Kennesaw, GA) and standard allografts operation during the study period. The Annals of Thoracic Surgery 2017 103, 869-874DOI: (10.1016/j.athoracsur.2016.07.068) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Distribution of diameters of implanted SynerGrafts (SGs; CryoLife, Kennesaw, GA) and standard allografts. The Annals of Thoracic Surgery 2017 103, 869-874DOI: (10.1016/j.athoracsur.2016.07.068) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Kaplan-Meier estimated 10-year survival, including hospital deaths, in SynerGraft (SG; CryoLife, Kennesaw, GA) and standard allograft recipients. (F/u = follow-up.) The Annals of Thoracic Surgery 2017 103, 869-874DOI: (10.1016/j.athoracsur.2016.07.068) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 4 Kaplan-Meier estimated 10-year freedom from conduit reintervention in SynerGraft (SG; CryoLife, Kennesaw, GA) and standard allograft recipients. The Annals of Thoracic Surgery 2017 103, 869-874DOI: (10.1016/j.athoracsur.2016.07.068) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 5 Kaplan-Meier estimated 10-year freedom from pulmonary insufficiency in SynerGraft (SG; CryoLife, Kennesaw, GA) and standard allograft recipients. (Echo F/u = echocardiography follow-up.) The Annals of Thoracic Surgery 2017 103, 869-874DOI: (10.1016/j.athoracsur.2016.07.068) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions